Your browser doesn't support javascript.
loading
Mycosis Fungoides and Sézary Syndrome: Microenvironment and Cancer Progression.
Dobos, Gabor; Lazaridou, Ingrid; de Masson, Adèle.
Afiliação
  • Dobos G; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt, 10117 Berlin, Germany.
  • Lazaridou I; Department of Dermatology, Universität zu Berlin, 10117 Berlin, Germany.
  • de Masson A; Dermatology, Brown University, Providence, RI 02912, USA.
Cancers (Basel) ; 15(3)2023 Jan 25.
Article em En | MEDLINE | ID: mdl-36765704
ABSTRACT
Mycosis fungoides and Sézary syndrome are epidermotropic cutaneous lymphomas, and both of them are rare diseases. Mycosis fungoides is the most frequent primary cutaneous lymphoma. In about 25% of patients with mycosis fungoides, the disease may progress to higher stages. The pathogenesis and risk factors of progression in mycosis fungoides and Sézary syndrome are not yet fully understood. Previous works have investigated inter- and intrapatient tumor cell heterogeneity. Here, we overview the role of the tumor microenvironment of mycosis fungoides and Sézary syndrome by describing its key components and functions. Emphasis is put on the role of the microenvironment in promoting tumor growth or antitumor immune response, as well as possible therapeutic targets. We focus on recent advances in the field and point out treatment-related alterations of the microenvironment. Deciphering the tumor microenvironment may help to develop strategies that lead to long-term disease control and cure.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article